Update: New Biomarkers Can Now be Used to Select Treatment for MBC
In our January 2023 issue, we discussed biomarkers for which there is not yet enough information to guide treatment decisions. Since then, clinical trials have...
Read More PAST ARTICLES
2024
- Nutrition and Exercise When Living With MBC
- Decoding Clinical Trial Terms: Umbrella, Basket, and Tumor Agnostic Clinical Trials
- Managing Symptoms When MBC Spreads to the Bones
- Targeting the Androgen Receptor in MBC
- Miami Breast Cancer Conference 2024
- Prioritizing Your Mental Health When Living With MBC
- Decoding Clinical Trial Terms: Arms
- Dato-DXd Antibody-Drug Conjugate for Triple-Negative and Hormone Receptor-Positive MBC
- Trial Alerts: Now Available on Metastatic Trial Search!
- Managing Side Effects of ADCs
- Leptomeningeal Disease: How is it Different from Brain Metastasis and How is it Treated?
- What is “Drug Sequencing”?
- Decoding Clinical Trial Terms: Dose Escalation and Dose Expansion
- Our New Partner: CancerBuddy
- Experts Break Down Important MBC Research from SABCS 2023
- Discovering New Ways to Overcome Treatment Resistance in Triple-Negative MBC
- Mark Your 2024 Calendars!
- Decoding Clinical Trial Terms: Clinical Trial Design
- Using Social Media to Find Support While Living With MBC
- Now Available: MBC Clinical Trials Infographic
- San Antonio Breast Cancer Symposium 2023
2023
- What Are FES PET Scans and How Are They Used for Lobular Breast Cancer?
- What’s the Difference Between Targeted Therapy and Chemotherapy?
- Advanced Breast Cancer Seventh International Consensus Conference (ABC7)
- Invasive Lobular Breast Cancer Symposium 2023
- Preparing for San Antonio Breast Cancer Symposium (SABCS) 2023
- How Does a Clinical Trial Benefit Me?
- FDA Approves Truqap
- Our New Partner: GRASP
- Our New Partner: Unite for HER
- European Society for Medical Oncology 2023
- What is a Biomarker and How are Biomarkers Used in Clinical Trials?
- Why Are MBC Outcomes Worse for Black Women Than White Women?
- Leaving a Legacy and Hope: Tissue Donation After Death
- Metastatic Trial Search Tutorial Videos: Now Available!
- Metastatic Breast Cancer Research Conference 2023
- Highlighting MBC Awareness Day and the MBC Alliance
- Overcoming Resistance to CDK4/6 Inhibitors
- What are Placebos and How Are They Used in MBC Clinical Trials?
- Non-Treatment Trials: Surveys, Interviews, and Registries
- Researching Ways to Make MBC Treatment Easier to Tolerate
- Meet the Clinical Trial Team: The Institutional Review Board
- In Memory of Dr. Susan Love
- The Latest Research on Inflammatory Breast Cancer
- Meet the Clinical Trial Team: The Clinical Trial Sponsor
- American Association for Cancer Research (AACR) 2023
- American Society for Clinical Oncology (ASCO) 2023
- How is ER Low Used in Clinical Trials?
- Non-Treatment Trials: Predicting Response to Treatment and Decision Support
- Artificial Intelligence and MBC: Can AI Improve Detection and Treatment?
- Meet the Clinical Trial Team: The Principal Investigator
- Living Beyond Breast Cancer Conference 2023
- Non-Treatment Trials: Managing Side Effects
- Shared Decision-Making: Collaborating with Your Doctors About Your Cancer Care
- The Latest Research on Lobular MBC
- What is the Microbiome and How Might it Affect MBC?
- Miami Breast Cancer Conference 2023
- Managing Other Health Conditions While Living with MBC
- Can I Participate in a MBC Clinical Trial if I Have Other Health Conditions?
- Meet the Clinical Trial Team: The Clinical Trial Coordinator
- What are Clinical Practice Guidelines and How are They Developed?
- Who are Clinical Trial Research Team Members?
- Dating and Relationships While Living with MBC
- New Clinical Trials For Stage IV Breast Cancer
- What to Know About MBC Treatment-Related Heart Problems
- ASCO Experts Update Guidance for Sacituzumab Govitecan (Trodelvy®) for HR+, HER2- MBC
- What are Non-Treatment Trials and Why are They Important?
- Black Wo(Men) Speak Symposium 2022
- FDA Approves Orserdu and Expands Approval of Trodelvy®
- New ESR1 Biomarker Research Leads to FDA Approval for ER+, HER2- MBC with an ESR1 Mutation
- What is Stable Disease and How is it Monitored?
- Self-Advocacy: Your Voice in Your Cancer Care
- Clinical Trial Participation: The Patient’s Journey
- Metastatic Trial Search Featured in Clinical Trials Webinar
- Biomarkers to Guide MBC Treatment Decisions: ESR1, PALB2, TROP2, HRD, ctDNA, and CTCs
- I Found a Trial I’m Interested In. What’s Next?
- An Overview of Insurance and Clinical Trials
- New Announcement: Metastatic Trial Search is Mobile-Friendly!
2022
- Biomarkers to Guide MBC Treatment Decisions: dMMR/MSI-H, TMB, and NTRK Fusion
- The Latest Research on CDK 4/6 Inhibitors
- Patient-Reported Outcomes: Including the Patient Voice in MBC Research
- Clinical Trial Outcomes: What is Being Studied and How is it Measured?
- Which Foods, Supplements, and Drugs Should I Avoid During MBC Treatment?
- Why You Should Consider Repeat Biopsies
- Biomarkers to Guide MBC Treatment Decisions: PIK3CA, BRCA1/BRCA2, and PD-L1/PD-1
- Oncolytic Viruses: Using Viruses to Kill Cancer Cells
- Lobular Breast Cancer Metastasis: Highlighting the Researchers
- What is Measurable Disease?
- CURE®’s Educated Patient® Metastatic Breast Cancer Summit
- New Announcement: Introduction to MBC Clinical Trials Video
- What is it Like to Participate in a Clinical Trial?
- FDA Approves Enhertu® for HER2-Low MBC
- Why Knowing Your HER2 Status is Important
- Breast Cancer Lung Metastasis: Highlighting the Experts
- How To Find Clinical Trial Results
- How To Choose a Cancer Center
- All About Vaccines for MBC
- How Trial Participation is Becoming Easier: Managing Finances, Travel, and Other Considerations
- Breast Cancer Liver Metastasis: Highlighting the Experts
- What Are Crossover Trials and How Do They Work?
- Are You Hesitant to Participate in Trials Because of Data Privacy?
- Breast Cancer Bone Metastasis: Highlighting the Experts
- How Trial Participation Is Becoming Easier: Decentralization
- FDA Expands Approval for Enhertu®
- Triple-Negative Metastatic Breast Cancer: Beyond ER, PR, and HER2
- Breast Cancer Brain Metastasis: Highlighting the Experts
- Patient Advocate Foundation, Our Newest Partner!
- Why Attend a Medical Conference?
- All About Phase IV Clinical Trials
- Update on Immunotherapy for MBC: Immune Checkpoint Inhibitors
- Why Do Some People Have an Exceptional Response When Being Treated for MBC?
- All About Phase III Clinical Trials
- What is Complementary and Integrative Medicine?
- Update On Antibody-Drug Conjugates (ADCs) For MBC
- All About Phase II Clinical Trials
- Why Does The Same Drug Work Differently In Different People?
- When We Tri(al) Our New Partner!
- Virtual Conferences: How Do I Prepare?
- All About Phase I Clinical Trials
- Male MBC Treatment And Clinical Trials
- MBCBrainMets.org – Our New Partner!
- Bispecific Antibodies: An Emerging Class Of MBC Drugs
- MBC and NED
- “Standard of Care” for MBC
- Treatment for MBC While Pregnant
- MBC-Related News from SABCS
2021
- Advanced Breast Cancer Conference 2021
- Scan Anxiety
- Treatment Strategies for Triple-Positive MBC
- What do FGFR Genetic Mutations Mean for You and Your MBC?
- Understanding Informed Consent
- Cannabis Use For Managing Symptoms and Side Effects
- Metronomic Chemotherapy: Looking at A New Way to Receive Treatment
- Lobular Metastatic Breast Cancer
- Financial Toxicity: Managing Costs While Enrolled in a Clinical Trial
- What are Solid Tumor Trials and Why Are They Important?
- Prepare For SABCS 2021
- Inflammatory MBC Treatments
- Pink October/MBC Awareness Day
- Steps Toward Expanding Eligibility Criteria to Increase Diversity in Clinical Trials
- Metastatic Breast Cancer News from 2021 ESMO
- Theragnostics
- Spotlight on the Tigerlily Foundation & Breast Cancer Racial Disparities
- Health Insurance for MBC
- Atezolizumab Immunotherapy Is Withdrawn From FDA-Approval Process
- Metastatic Trial Search: New Features
- Metastatic Breast Cancer News from ASCO 2021
- FDA Fast Track
- Adoptive Cell Therapies: A Type of Immunotherapy for MBC
- Black Breast Cancer & BRCA1/2 Mutations
- Immunotherapy Resistance
- Modernizing Clinical Trials
- Update on Oral SERDs for Estrogen Receptor-Positive MBC
- MBC News from 2021 AACR Meeting
- Videos About Breast Cancer Clinical Trials
- Lymphodepletion in Cancer Immunotherapy
- Where You Can Find Current MBC Research
- Local Therapies for Liver Mets
- Y-90 Internal Radiation Therapy for Liver Mets
- St. Gallen International Breast Cancer Conference 2021
- Spotlight on New Partners
- 2021 Miami Breast Cancer Conference
- Just-in-Time Trials
- The Latest Research on Hormone Receptor-Positive (HR+) MBC
- Side Effects of Radiation Therapy for Brain Mets
- Other MBC Resources
- Metastatic Breast Cancer in the LGBTQI Communities
- Expanded Access
- 2021 Update on Metastatic Triple Negative Breast Cancer Treatment
- Screening for Breast Cancer Brain Metastases
- Participating in a Trial: Patient Voices
- FDA Approves MARGENZA
- Treating Breast Cancer Brain Mets
- Circulating Tumor Cell Testing
- What is a Washout Period?
- Spotlight on MBC Podcasts
- What is Next-Generation Sequencing?
- Lines of Therapy: New Drugs May Change MBC Treatment
- What Are “Lines of Therapy”?
- Warmest Wishes for 2021
2020
- When to Use Surgery & Radiation to the Breast
- Metastatic Trial Search: New & Improved
- Body Image and Metastatic Breast Cancer
- Individualized Dosing for People with MBC
- FDA Approves Keytruda®
- Art Therapy for People with MBC
- HER2-Low Expressing: A New Subcategory of HER2-Negative Breast Cancer?
- How to Prepare for a Virtual SABCS
- MBC, Advanced Breast Cancer & Locally Advanced Breast Cancer: What’s in a Name?
- Living with Metastatic Breast Cancer During October
- Imaging Tests for People with Stage IV Breast Cancer
- The Impact of MBC on Work and Career
- PD-L1 Biomarker for Immunotherapy
- Depression & Metastatic Breast Cancer
- LBBC’s Conference on Metastatic Breast Cancer
- Metastatic Breast Cancer at a Young Age
- How Participants are Divided into Treatment Groups in Clinical Trials
- Sexual Side Effects of MBC Treatment
- What is ER-Low Breast Cancer?
- Clinical Trials Are Not Only a Last Resort
- Spotlight on Metastatic Breast Cancer in Older People
- FDA Approves PHESGO
- HER2 Positive Metastatic Breast Cancer Research Update
- Peer Support for Metastatic Breast Cancer
- How to Find Metastatic Breast Cancer Clinical Trials
- Introduction to MBC Clinical Trials
- Telemedicine in Clinical Trials
- Recent FDA Approvals for Metastatic Breast Cancer
- What is a Patient Navigator?
- Find Trials That Are Right For You
- Managing Anxiety
- The Tumor Microenvironment
- Komen LA MBC Conference
- Black Women Facing Breast Cancer
- Do You Know Your Rights as a Cancer Patient?
- What is Your Tumor’s Mutation Burden?
- MBC in the Transgender Community
- Commonly Used Terms in Clinical Trials
- Exercise and Stage 4 Breast Cancer
- How To Get a Newly Approved Cancer Drug
- Triple-Negative Breast Cancer Update
- True or False?
- New Features on MTS
- Cancer & PTSD
- Big Data & Cancer Research
2019
- Warmest Wishes
- Tips for Reading Cancer News
- What Do Drug Names Mean?
- Getting Through the Holidays While Living with MBC
- Diagnosing & Treatment of Bone Metastases
- What is a Tumor Agnostic Therapy?
- True or False?
- Expanding Eligibility Criteria
- Dragon Boat Racing
- Genetic vs. Genomic Testing
- About MBC Awareness Day
- Treating Brain Metastases
- OS vs. PFS: What You Need to Know
- How to Ask Your Doctor About Clinical Trials
- More Men Needed in Breast Cancer Trials
- New FDA Approval: A PI3K Inhibitor
- True or False?
- New Guideline Includes Immunotherapy
- How to Get a Medical Interpreter
- Should You Get A Second Opinion?
- What is Oligometastatic Breast Cancer?
- Doctors & Patients on Clinical Trials
- Genomic Testing: What Makes Your Tumor Grow?
- MBC Facebook Groups
- Treatment Guidelines for Metastatic Breast Cancer
- Metastatic Breast Cancer Blogs
- Why the Phase of a Clinical Trial Matters
- Planning Ahead: Advance Care Plans
- The Future of Metastatic Breast Cancer Treatment
- First Immunotherapy Approved for MBC
- Video Portraits of MBC
- Coordinating Support for You and Your Family
- Palliative Care
- The Latest Research on ctDNA and MBC
- From Down Under: Stories of MBC
- What Are Master Protocols?
- ¿Hablas Español?
- Learn From Home With a Webinar
- Get the Latest News on PARP Inhibitors
- Life with MBC: 10+ Years and Counting
- All about Basket and Umbrella Trials
- Consider a Retreat
- What is CAR-T Cell Immunotherapy?
- New Research Presented at San Antonio
- Patient and Advocate Perspectives on San Antonio
- Support for MBC Caregivers
- Managing Lymphedema
2018
- Reporting Side Effects in Cancer Clinical Trials
- Stories of De Novo Breast Cancer
- Evidence-Based Information on Herbs and Supplements
- Your Tumor and Experience Could Lead to New Treatments
- Thriving at a Cancer Conference
- MBC Patients in The News
- Talking to Kids About MBC
- Biosimilar Drugs & Breast Cancer
- Immunotherapy & Metastatic Breast Cancer
- Living with Triple Negative MBC
- The Lack of Diversity in Clinical Trials
- Where to Find Financial Support
- Insights into Treatment Resistance
- Speaking Out on Inflammatory Breast Cancer
- Perspectives on Clinical Trials
- Living with MBC
- Managing Pain While Living with MBC
- Voices of Men with MBC
- Finding Support Groups
- CRISPR & Cancer
- Treating BRCA1/2 Metastatic Breast Cancer
- Metastatic Breast Cancer Advocacy
- Clinical Trials: Who Gets to Take Part?
- Share Links, Give Feedback, Tell Us Your Story
- Looking for a Helpline?
- Chemo, Second Opinions & Disability Insurance
SEARCH OUR SITE
for past articles or specific information.